Carmustine in Treating Patients With Recurrent Malignant Glioma

NCT00004028 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: carmustine
PROCEDURE: conventional surgery

Sponsor

National Cancer Institute (NCI)